RT Book, Section A1 Fitzpatrick, Meghan E. A1 Prendergast, Niall T. A1 Rivera-Lebron, Belinda A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1193146076 T1 Pneumonia T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193146076 RD 2024/04/23 AB Pneumonia has classically been considered in terms of the infecting organism (Table 9–8) (eFigures 9–7, 9–8, 9–9, and 9–10). This approach facilitates discussion of characteristic clinical presentations but is a limited guide to patient management since specific microbiologic information is usually not available at initial presentation. Current classification schemes emphasize epidemiologic factors that predict etiology and guide initial therapy. Pneumonia may be classified as community-acquired pneumonia (CAP) or nosocomialpneumonia and, within the latter, as hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP). These categories are based on differing settings and infectious agents and require different diagnostic and therapeutic interventions. Anaerobic pneumonia and lung abscess can occur in both hospital and community settings.